Haemonetics HAE
NYSE HAE
$101.14 -2.02 (-1.96%)
As of: Sep 10, 2026 · 3:59 PM EDT

Haemonetics (HAE) Work In Process (2011)

Haemonetics (HAE) posted Work In Process of $4.3 million for Q4 2011, down 17.21% on a QoQ basis from $5.2 million in Q3 2011.

Analysis

Haemonetics (HAE) Work In Process (2011) Analysis & Trends

Haemonetics has reported Work In Process for 1 years, with the latest figure at $4.3 million in Q4 2011.

  • On a quarterly basis, Work In Process changed N/A year-over-year to $4.3 million in Q4 2011; TTM through Oct 2011 was $4.3 million, a N/A change from a year earlier, with the FY2011 full-year figure at $4.4 million, changed N/A from the prior year.
  • Work In Process was $4.3 million for Q4 2011 at Haemonetics, down from $5.2 million in the prior quarter.
  • The five-year high for Work In Process was $5.2 million in Q3 2011, with the low at $4.3 million in Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Haemonetics 4.60 Bn 4.37 Bn 202.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Oct 1, 2011 4.30 Mn
Jul 2, 2011 5.20 Mn
Apr 2, 2011 4.35 Mn